With the "COVID-19 Knowledge Space", Fraunhofer SCAI – together with Fraunhofer IME, Fraunhofer IAIS, the Information Center for Life Sciences ZBMED and other research partners – is opening a new kind of knowledge space with analysis tools and information on COVID-19. This website provides central services that allow access to publicly available data on current COVID-19 research. Fraunhofer IME at its site in Hamburg will contribute its expertise in linking chemical information of drug molecules with antiviral properties against COVID-19 and other data, such as toxicity and possible side effects.